Profile data is unavailable for this security.
About the company
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.
- Revenue in CAD (TTM)24.87m
- Net income in CAD-7.44m
- Incorporated2016
- Employees38.00
- LocationAvicanna Inc480 UNIVERSITY AVENUE, SUITE 1502TORONTO M5G 1V2CanadaCAN
- Phone+1 (647) 243-5283
- Fax+1 (647) 243-5283
- Websitehttps://avicanna.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resverlogix Corp | 0.00 | -14.97m | 18.07m | 18.00 | -- | -- | -- | -- | -0.0575 | -0.0575 | 0.00 | -0.391 | 0.00 | -- | -- | 0.00 | -138.80 | -- | -- | -- | -- | -- | -- | -- | 0.0459 | -0.8227 | -- | -- | -- | -- | -363.74 | -- | -- | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 18.39m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -4.49m | 26.84m | -- | -- | 5.64 | -- | -- | -0.1092 | -0.1092 | 0.00 | 0.1045 | 0.00 | -- | -- | -- | -91.94 | -- | -98.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Numinus Wellness Inc | 20.10m | -24.36m | 29.01m | -- | -- | 6.23 | -- | 1.44 | -0.0906 | -0.0946 | 0.0752 | 0.0145 | 0.8572 | -- | 11.72 | -- | -103.89 | -77.31 | -129.39 | -84.20 | 30.80 | -- | -121.19 | -323.32 | -- | -13.08 | 0.6044 | -- | 256.95 | -- | 32.59 | -- | -- | -- |
| Avicanna Inc | 24.87m | -7.44m | 29.04m | 38.00 | -- | 788.61 | -- | 1.17 | -0.0804 | -0.0804 | 0.2714 | 0.0003 | 1.20 | 2.95 | 9.32 | 654,600.00 | -35.85 | -67.17 | -267.70 | -167.73 | 48.66 | 46.36 | -29.90 | -368.82 | 0.3316 | -8.88 | 0.1645 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Briacell Therapeutics Corp | 0.00 | -6.68m | 31.90m | 17.00 | -- | -- | -- | -- | -0.4286 | -0.4286 | 0.00 | -0.1817 | 0.00 | -- | -- | 0.00 | -29.86 | -52.94 | -40.97 | -57.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 76.40 | -- | -- | -- |
| Helix Biopharma Corp. | 0.00 | -9.27m | 34.32m | 7.00 | -- | -- | -- | -- | -0.1951 | -0.1951 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -735.90 | -269.35 | -- | -10,777.24 | -- | -- | -- | -- | -- | -355.35 | -- | -- | -- | -- | -47.28 | -- | 28.47 | -- |
| KDA Group Inc | 204.14k | -876.18k | 35.14m | -- | -- | 2.44 | -- | 172.14 | -0.0027 | 0.0783 | 0.0013 | 0.0821 | 0.008 | -- | 0.0835 | -- | -4.63 | -17.96 | -8.47 | -44.69 | 33.32 | 26.76 | -574.97 | -28.00 | -- | -7.08 | 0.0606 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
| Nurexone Biologic Inc | 0.00 | -5.78m | 42.37m | 8.00 | -- | 11.22 | -- | -- | -0.1112 | -0.1112 | 0.00 | 0.0535 | 0.00 | -- | -- | -- | -183.97 | -213.78 | -235.34 | -596.97 | -- | -- | -- | -- | -- | -187.27 | 0.0096 | -- | -- | -- | 55.45 | -- | -- | -- |
